Exploring the osteogenic potential of semisynthetic triterpenes from Combretum leprosum: An in vitro and in silico study

• Published in: In vitro cellular & developmental biology. Animal Vol. 60; no. 8; pp. 853 - 867
• Main Authors: Nogueira-Júnior, Valdo, Sousa, Fátima Regina N., da S. M. Rebouças, Conceição, Braz, Helyson L. B., dos S. Morais, Maria Luana G., Goes, Paula, de C. Brito, Gerly Anne, Jorge, Roberta Jeane B., Barbosa, Francisco Geraldo, Mafezoli, Jair, Silva-Filho, Carlos José A., de O. Capistrano, André Luiz, Bezerra, Mirna M., de C. Leitão, Renata F.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01-09-2024
• Subjects: Animal Genetics and Genomics; Biomedical and Life Sciences; Cell Biology; Cell Culture; Developmental Biology; Life Sciences; Stem Cells; Triterpenes; Mineralization; Osteoblasts; Bioinformatics; Combretum leprosum
• ISSN: 1071-2690; 1543-706X; 1543-706X
• DOI: 10.1007/s11626-024-00928-w

Combretum leprosum
Mart. is a plant of the Combretaceae family, widely distributed in the Northeast region of Brazil, popularly used as an anti-inflammatory agent, and rich in triterpenes. This study evaluated in vitro and in silico potential osteogenic of two semisynthetic triterpenes (CL-P2 and CL-P2A) obtained from the pentacyclic triterpene 3β,6β,16β-trihydroxylup-20(29)-ene (CL-1) isolated from
C. leprosum
. Assays were carried out in cultured murine osteoblasts (OFCOL II), first investigating the possible toxicity of the compounds on these cells through viability assays (MTT). Cell proliferation and activation were investigated by immunohistochemical evaluation of Ki-67, bone alkaline phosphatase (ALP) activity, and mineralization test by Von Kossa. Molecular docking analysis was performed to predict the binding affinity of CL-P2 and CL-P2A to target proteins involved in the regulation of osteogenesis, including: bone morphogenetic protein 2 (BMP-2), proteins related to Wingless-related integration (WNT) pathway (Low-density lipoprotein receptor-related protein 6—LRP6 and sclerostin—SOST), and receptor activator of nuclear factor (NF)-kB-ligand (RANK-L). Next, Western Blot and immunofluorescence investigated BMP-2, WNT, RANK-L, and OPG protein expressions in cultured murine osteoblasts (OFCOL II). None of the CL-P2 and CL-P2A concentrations were toxic to osteoblasts. Increased cell proliferation, ALP activity, and bone mineralization were observed. Molecular docking assays demonstrated interactions with BMP-2, LRP6, SOST, and RANK-L/OPG. There was observed increased expression of BMP-2, WNT, and RANK-L/OPG proteins. These results suggest, for the first time, the osteogenic potential of CL-P2 and CL-P2A.